Viking Fund Management LLC raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Repor...
The dollar’s worst start to a year on record, Bristol Myers plans to develop new cancer drug, Apple’...
At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific ant...
We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are goin...
Bristol Myers Squibb’s partnership with BioNTech makes it the third big pharma company to strike a d...